Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Trump Plans to Impose 50% Tariff on Imported Copper, Pharmaceutical Tariffs May Reach 200%

Trump Plans to Impose 50% Tariff on Imported Copper, Pharmaceutical Tariffs May Reach 200%

金色财经金色财经2025/07/08 18:02
Show original

According to a report by Jinse Finance, U.S. President Trump told reporters during a cabinet meeting on Tuesday that more trade agreements are forthcoming, particularly in the form of letters in which the U.S. unilaterally sets tariff rates. "These agreements are basically me making demands of them," Trump said. "The numbers we choose are both low and fair." Trump added that the U.S. will impose a new 50% tariff on imported copper. "Today, we're targeting copper. I think we'll set the copper tariff at 50%." In response, New York copper futures surged, with intraday gains expanding to as much as 17%. In addition, Trump stated that the U.S. will soon impose tariffs of up to 200% on pharmaceuticals, but companies will have a year and a half to adjust their supply chains before the tariffs take effect. Trump also said he would soon announce tariffs on semiconductors, though he did not specify the tariff rate or the implementation date.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.

智通财经2026/09/14 01:06
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas